Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Innovative liver cancer treatment gets EU approval

Innovative liver cancer treatment gets EU approval

Delcath expands global Phase 2 program to treat hepatocellular carcinoma

Delcath expands global Phase 2 program to treat hepatocellular carcinoma

UC Davis researchers unravel how micro RNA could potentially lead to novel cancer therapies

UC Davis researchers unravel how micro RNA could potentially lead to novel cancer therapies

NASH patients more likely to have increased intestinal permeability, shows study

NASH patients more likely to have increased intestinal permeability, shows study

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

Can-Fite, Cipher Pharmaceuticals sign agreement to distribute CF101 in Canada

Can-Fite, Cipher Pharmaceuticals sign agreement to distribute CF101 in Canada

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

Parenchymal preservation surgery linked to lower mortality, complication rates in cancer patients

Parenchymal preservation surgery linked to lower mortality, complication rates in cancer patients

Study describes the dual role of microRNA during hepatitis C infection

Study describes the dual role of microRNA during hepatitis C infection

WHO releases first-ever guidance for chronic hepatitis B treatment

WHO releases first-ever guidance for chronic hepatitis B treatment

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Women for Positive Action introduces new educational tool for women living with HIV

Women for Positive Action introduces new educational tool for women living with HIV

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

Scientists detect new molecule that contributes to development of liver fibrosis

Scientists detect new molecule that contributes to development of liver fibrosis

SLU researchers halt fatty liver disease in animal model

SLU researchers halt fatty liver disease in animal model

USPTO issues Notice of Allowance to Can-Fite BioPharma for psoriasis patent

USPTO issues Notice of Allowance to Can-Fite BioPharma for psoriasis patent

GI Society releases video to spread awareness about hepatitis C

GI Society releases video to spread awareness about hepatitis C

HCV more common in West Africa yet lacks equal attention as HIV/AIDS or Ebola

HCV more common in West Africa yet lacks equal attention as HIV/AIDS or Ebola

41% of the British population unaware of the role of diet in cancer development

41% of the British population unaware of the role of diet in cancer development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.